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Epidemic
Clostridium difficile
Strain in Hospital
Visitation Dog
To the Editor: Rates of illness and
death from Clostridium difficile–asso-
ciated disease (CDAD) and reports of
CDAD in persons without traditional
risk factors (1) have been increasing.
One particular strain of C. difficile has
been implicated in outbreaks of
CDAD in hospitals in North America
and Europe and appears to be spread-
ing internationally at an alarming rate.
This strain is classified as ribotype
027, toxinotype III, and possesses
genes encoding toxins A, B, and CDT
(binary toxin) as well as a deletion in
the tcdC gene, which is believed to
increase virulence (2).
We report this toxin-variant strain
of C. difficile in a healthy, 4-year-old
toy poodle that visits persons in hos-
pitals and long-term care facilities in
Ontario on a weekly basis. C. difficile
was isolated from a fecal sample col-
lected in the summer of 2004 as part
of a cross-sectional study evaluating
pathogen carriage by visitation dogs
(3). The isolate was subsequently
characterized by ribotyping (4) and by
polymerase chain reaction (PCR)
detection of genes that encode pro-
duction of toxins A and B (5). Toxin
CDT was confirmed by amplifying
the portion of the gene (cdtB) that
encodes for the receptor-binding com-
ponent of the toxin, according to a
previously reported protocol (6). As a
result, the isolate was classified as
ribotype 027, toxinotype III (7), and
was found to possess all 3 toxin
genes. The tcdC gene deletion was
also confirmed with PCR (8).
These results indicate that this
canine isolate is indistinguishable
from the major strain implicated in
outbreaks of highly virulent CDAD
around the world. According to the
infection control practitioner at the
hospital the dog visited, CDAD cases
were occurring at increased frequency
in the facility around the time the
dog’s fecal specimen was collected.
However, patient diagnosis was made
solely through fecal toxin testing, and
strains were not characterized. The
facility has reported only sporadic
cases of CDAD in the past few years.
This is the first report of this
human, epidemic strain of C. difficile
in a dog. Many C. difficile strains iso-
lated from animals, including dogs,
are indistinguishable from strains
associated with disease in humans (9).
To date, no study, including this one,
has shown that interspecies transmis-
sion occurs; however, that possibility
exists, as is becoming apparent with
other pathogens, such as methicillin-
resistant Staphylococcus aureus. The
recurrent exposure of this dog to
human healthcare settings suggests
that the animal acquired this strain
during visits to the hospital or long-
term care facility, either from the
healthcare environment or contami-
nated hands of human contacts. We
recommend that future studies evalu-
ating the dissemination of this strain
and investigations of the movement of
C. difficile into the community con-
sider the role of animals.
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Streptobacillus
moniliformis
Endocarditis
To the Editor: Streptobacillus
moniliformis is a facultatively anaero-
bic, pleomorphic, gram-variable bacil-
lus often seen in chains and as long
unbranched filaments. It is found in
the nasopharynx and oropharynx of
wild and laboratory rats. Human infec-
tions result either from rodent bites
(rat bite fever) or contaminated milk
or other foods (Haverhill fever). The
most common manifestations of infec-
tion are arthralgia, fever, and rash;
endocarditis occurs as a rare complica-
tion (1). We report a case of S. monili-
formis endocarditis in India in a
patient with congenital heart disease.
An 18-year-old man was admitted
to the Department of Cardiology at
the Government General Hospital in
Chennai, India, in November 2005,
with a fever of 2 months’ duration
with cough, epistaxis, palpitations,
and persistent joint pain. His medical
history indicated congenital heart dis-
ease with a ventricular septal defect.
On physical examination, his blood
pressure was 100/70 mm Hg, pulse
rate was 100 beats/min, and tempera-
ture was 38.5°C. Laboratory tests
showed a leukocyte count of 7,600/µL,
a platelet count of 127,000/µL, and an
erythrocyte sedimentation rate of 70
mm/h. An electrocardiogram showed
normal sinus rhythm. A transthoracic
echocardiogram demonstrated a ven-
tricular septal defect and vegetations
on the septal leaflet of the tricuspid
valve.
Three blood cultures were pre-
pared, and treatment with antimicro-
bial drugs (intravenous penicillin G, 3
×  106 Uevery 6 h, and gentamicin, 50
mg every 8 h for 4 weeks) was initiat-
ed. The blood cultures were incubated
at 37°C in an atmosphere of 5%–10%
CO2. Characteristic white, downy,
crumblike granules were observed on
the surface of the erythrocytes in all 3
cultures within 18–24 h of incubation.
Characteristic puff balls were seen
after 48 h of incubation. Gram-stained
smears showed gram-negative bacilli
in long chains. Cultures were subcul-
tured onto 5% sheep blood agar plates
and MacConkey agar plates. The
plates were incubated at 37°C in an
atmosphere of 5%–10% CO2. After
18–24 h of incubation, growth was
seen on the sheep blood agar plates.
Colonies were 1–2 mm in diameter,
gray, smooth, and butyrous. A Gram
stain of these colonies identified gram-
variable, pleomorphic coccobacilli
that were negative for catalase, oxi-
dase, urease, and citrate, and did not
produce indole or reduce nitrate.
Antimicrobial susceptibility testing
was performed by using the Kirby-
Bauer disk diffusion method accord-
ing to recommendations of the
National Committee for Clinical labo-
ratory Standards (2). The isolate was
sensitive to penicillin G, ceftriaxone,
cephalexin, amoxicillin, gentamicin,
and erythromycin. The patient
responded well to treatment and
became afebrile within 48 h after initi-
ation of therapy. Treatment with
antimicrobial drugs was continued for
4 weeks. The blood cultures were neg-
ative when repeated after 2 weeks. The
patient had an uneventful recovery and
was discharged from the hospital.
Rat bite fever is a zoonosis caused
by either Streptobacillus moniliformis
or  Spirillum minus (1,3).  S. monili-
formis is found in the nasopharynx of
small rodents, especially rats. Rats
that are carriers have no symptoms
but can effectively transmit the infec-
tion by bite or through infected body
fluids such as urine. 
This patient had a history of living
in a rat-infested area, and admitted
having been bitten by a rat several
months before the onset of symptoms.
However, we considered it unlikely
that disease contracted by a rat bite
would take months to be manifested.
Thus, it is more likely that he con-
tracted the infection from food or
water contaminated with rat excreta.
Endocarditis is a rare complication of
S. moniliformis infection, and cardiac
valvular abnormalities have been
reported in 50% of cases (4). This
patient, however, had only a small
ventricular septal defect. This is the
first report of S. moniliformis endo-
carditis from India.
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